SCHEMBL505306

SCHEMBL505306

COc1cccc(-c2ccc(C=O)c(F)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.56
MAOB P27338 2/20 0.48
ALDH1A1 P00352 3/20 0.47
BRD4 O60885 1/20 0.47
HDAC4 P56524 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
TRIM24 O15164 1/20 0.46
TYR P14679 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
MAP4K4 O95819 1/20 0.46
RPS6KA3 P51812 1/20 0.45
DHODH Q02127 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP1A1 P04798 1/20 0.44
CYP2E1 P05181 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2A6 P11509 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1125382 0.85 ERN1 (0.53) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL5736548 0.83 ERN1 (0.69) ERN1ALDH1A1BRD4HDAC4HDAC8
SCHEMBL245504 0.81 ALDH1A1 (0.63) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL13971260 0.80 ERN1 (0.51) ERN1HDAC8DHODHCYP1A2CYP2C19
Hydrochloric Acid SCHEMBL28823895 0.80 ALDH1A1 (0.61) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL28757325 0.80 ERN1 (0.54) ERN1MAOBALDH1A1BRD4HDAC4
SCHEMBL4557432 0.79 DRD1 (0.37) ERN1DHODHCYP1A2CYP2C19
SCHEMBL19154093 0.79 ERN1 (0.50) ERN1ALDH1A1BRD4TRIM24TYR
SCHEMBL1639484 0.78 ERN1 (0.68) ERN1HDAC4HDAC8TRIM24TYR
SCHEMBL1591812 0.78 ERN1 (0.46) ERN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
EP-2414328-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS Merck Serono S.A. (CH) 2012-02-08 EP disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed
WO-2010115736-A2 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2010-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD ERN1 3104/4885MAOB 513/4885ALDH1A1 95/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.